Skip to main content
. 2022 Dec 5;12(12):e1118. doi: 10.1002/ctm2.1118

FIGURE 5.

FIGURE 5

CD70 genetic aberrations predict inferior overall survival in Chinese diffuse large B‐cell lymphoma (DLBCL) patients. (A) DLBCL patients with CD70 genetic aberrations had a shorter OS than those with wild‐type CD70. The P‐value was calculated by the log‐rank test. HR (95% CI): 1.849 (1.139–3.002). (B–E) Kaplan–Meier survival curve of overall survival in the CD70 wild‐type group and CD70 gene‐altered group within the indicated cohorts. The P‐value was calculated by the log‐rank test. HR (95% CI): GCB: 0.980 (0.430–2.238); non‐GCB: 2.878 (1.564–5.294); R‐CHOP, 1.577 (0.771–3.224); CHOP, 1.988 (0.815–4.852).